P3 Health Partners Net Profit Margin 2020-2025 | PIII

P3 Health Partners net profit margin from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
P3 Health Partners Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-09-30 $1.45B $-0.13B -9.07%
2025-06-30 $1.46B $-0.15B -9.99%
2025-03-31 $1.49B $-0.14B -9.29%
2024-12-31 $1.50B $-0.14B -9.13%
2024-09-30 $1.48B $-0.10B -6.98%
2024-06-30 $1.40B $-0.07B -4.92%
2024-03-31 $1.35B $-0.07B -4.96%
2023-12-31 $1.27B $-0.06B -4.50%
2023-09-30 $1.18B $-0.13B -10.71%
2023-06-30 $1.14B $-0.12B -10.91%
2023-03-31 $1.08B $-0.27B -24.88%
2022-12-31 $1.05B $-0.27B -25.74%
2022-09-30 $0.98B $-0.25B -25.20%
2022-06-30 $0.88B $-0.27B -30.20%
2022-03-31 $0.76B $-0.14B -18.68%
2021-12-31 $0.64B $-0.16B -24.49%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.015B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $30.189B 34.91
Tempus AI (TEM) United States $9.769B 0.00
Hims & Hers Health (HIMS) United States $5.240B 42.63
Doximity (DOCS) United States $5.221B 22.18
IRhythm Holdings (IRTC) United States $4.719B 0.00
Privia Health (PRVA) United States $2.705B 169.15
Hinge Health (HNGE) United States $2.454B 0.00
Heartflow (HTFL) United States $2.362B 0.00
10x Genomics (TXG) United States $2.355B 0.00
Inspire Medical Systems (INSP) United States $1.909B 31.59
Omnicell (OMCL) United States $1.664B 46.34
Azenta (AZTA) United States $1.321B 53.19
Enovis (ENOV) United States $1.292B 6.78
Clover Health Investments (CLOV) United States $1.101B 0.00
Schrodinger (SDGR) United States $0.994B 0.00
Butterfly Network (BFLY) United States $0.854B 0.00
Phreesia (PHR) United States $0.736B 0.00
Fulgent Genetics (FLGT) United States $0.725B 0.00
Talkspace (TALK) United States $0.643B 129.33
Standard BioTools (LAB) United States $0.485B 0.00
Claritev (CTEV) United States $0.428B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Evolent Health (EVH) United States $0.318B 0.00
Carlsmed (CARL) United States $0.310B 0.00
TruBridge (TBRG) United States $0.304B 13.97
Senseonics Holdings (SENS) United States $0.304B 0.00
Zepp Health (ZEPP) Netherlands $0.256B 0.00
CapsoVision (CV) United States $0.232B 0.00
KORU Medical Systems (KRMD) United States $0.228B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.210B 0.00
MDxHealth SA (MDXH) Belgium $0.167B 0.00
Nyxoah SA (NYXH) Belgium $0.158B 0.00
Health Catalyst (HCAT) United States $0.152B 0.00
CareCloud (CCLD) United States $0.104B 5.70
Outset Medical (OM) United States $0.082B 0.00
American Well (AMWL) United States $0.073B 0.00
NetraMark Holdings (AINMF) Canada $0.065B 0.00
111 (YI) China $0.064B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
HeartBeam (BEAT) United States $0.049B 0.00
EUDA Health Holdings (EUDA) Singapore $0.042B 0.00
Precipio (PRPO) United States $0.035B 0.00
Evaxion - (EVAX) Denmark $0.028B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.016B 0.00
Movano (MOVE) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
ITonic Holdings (ITOC) China $0.007B 0.00
Bullfrog AI Holdings (BFRG) United States $0.007B 0.00
Strata Skin Sciences (SSKN) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.006B 0.00
PROFUSA (PFSA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00